Skip to main content
The NCI Community Hub will be retiring in May 2024. For more information please visit the NCIHub Retirement Page:https://ncihub.cancer.gov/groups/ncihubshutdown/overview
close
  • Discoverability Visible
  • Join Policy Open/Anyone
  • Created 02 Sep 2022

Sixth ISC Workshop on HPC Applications in Precision Medicine 

May 25, 2023 | Hamburg, Germany

Conference Website: http://isc-hpc.com

Call for Abstracts Submission Site: https://easychair.org/cfp/HAPM23

Abstract Submission Deadline Extended: April 13, 2023

Important Dates

Abstract Submission Deadline April 13, 2023
Notification of Acceptance April 19, 2023
Early Bird Registration Rate Deadline April 19, 2023
Workshop May 25, 2023

 

Program Overview

High performance computing has become central to the future success of precision medicine.
The dramatic increase in the volume of research and clinical data available through medical records, imaging technologies, sequencing, biometric sensors, and mobile health devices, has also opened many new frontiers for AI in medicine.  Powered new computing platforms from edge to exascale, there is a critical convergence where HPC is shaping the future for medicine, from cancer to infectious diseases, to drug discovery, to digital twins, to critical decisions in hospital intensive care units.
Not surprisingly, the growth of opportunities for HPC in medicine applications continues to accelerate, powered many successful efforts including EU funded CompBioMed, the European Center of Excellence for Personalized Medicine (PerMedCoE), the newly UK funded CompBioMedX, US NIH Bridge2AI and a growing number of new opportunities globally. The workshop will highlight these opportunities, the convergence of experiment, modeling, AI and data, and the collaborations needed to address an absence of data, a need for standards, overcoming data bias, ethical use of AI approaches, and building confidence in HPC solutions to some of the most challenging problems in medicine.
The previous five HPC Applications of Precision Medicine (HAPM) workshops have been very successful. Building on the fourth workshop which was held virtually in 2021 and attracted attendees globally, the workshop continued in 2022 with in-person attendees internationally and a wonderful panel exploring the path forward for digital twins in biomedicine. Again, a tremendously valuable workshop exploring leading-edge topics in the use of HPC in precision medicine, the participants resoundingly were in support of continuing the workshop in 2023. Following a strategy guiding the workshop, the HAP23 will focus on the next phase of successful introduction of HPC into biomedical workflows including the introduction of digital twins and predictive models from research to clinical application.
With the combined interest from a growing group of in-person attendees, ISC is now serving as a key ongoing hub for collaborative discussion in HPC in precision medicine, drawing from across Europe as well as North America and Asia. The HPC Applications in Precision Medicine workshop is fulfilling its aim to bring together the international computational and life sciences communities to share experiences, examine current challenges, and explore future opportunities for applications of high-performance computing in precision medicine.

Target Audience

The workshop is designed for scientists from multiple disciplines, from academic to commercial organizations, pharma, health care organizations and medical schools with interests in discussing computational approaches in medicine, from research to clinical, avenues for providing access to data, opportunities for use of AI, and those building new collaborations to deliver solutions improving the lives of us all.

Workshop Organizing Committee

  • Eric Stahlberg – Frederick National Laboratory for Cancer Research
  • Charles Gillan – University of Belfast (UK)
  • Andrea Townsend-Nicholson – University College London (UK)
  • Arnau Montagud – Barcelona Supercomputer Center (BSC) (Spain)
  • Jan Nygard – Cancer Registry of Norway
  • Thomas Steinke – Zuse Institute Berlin
  • Lynn Borkon – Frederick National Laboratory for Cancer Research
  • Petrina Hollingsworth – Frederick National Laboratory for Cancer Research 
Created by Petrina Hollingsworth Last Modified Thu April 6, 2023 9:38 am by Petrina Hollingsworth